BioPharma Dive5h
Mixed results for Keytruda; AbbVie to work with Neomorph
Merck and Eisai reported new data for a drug regimen of Keytruda and Lenvima. Elsewhere, AstraZeneca expanded in Canada and ...
bovnews10h
Newegg Commerce Inc (NEGG) Posted – Profit Margin Last Year—Can It Hold Up?
In recent trading, Newegg Commerce Inc (NEGG) stock price has shown some volatility, fluctuating 12.47% over the last five trades and 8.08% over the past 30 trades. This represents a notable shift ...
bovnews10h
Vigil Neuroscience Inc (VIGL) Reported a – Operating Margin Last Year—What’s the Real Story?
William Blair has recently initiated Vigil Neuroscience Inc (VIGL) stock to Outperform rating, as announced on December 4, 2024, according to Finviz. Earlier, on December 19, 2023, Morgan Stanley had ...
The Pharma Letter11h
Vigil moves into Phase II with Alzheimer's pill
Vigil Neuroscience advances VG-3927, a small molecule TREM2 agonist, into Phase II Alzheimer’s trials in Q3 2025 following ...